PDE7B
3',5'-cyclic-AMP phosphodiesterase 7B
Also known as: PDE7B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NP56
- Gene
- PDE7B
- Ensembl
- ENSG00000171408
- Chromosome
- 6
- Canonical length
- 450 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a cAMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family.[provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
450 residues, UniProt reviewed canonical sequence.
>Q9NP56|PDE7B
1 MSCLMVERCG EILFENPDQN AKCVCMLGDI RLRGQTGVRA ERRGSYPFID FRLLNSTTYS
61 GEIGTKKKVK RLLSFQRYFH ASRLLRGIIP QAPLHLLDED YLGQARHMLS KVGMWDFDIF
121 LFDRLTNGNS LVTLLCHLFN THGLIHHFKL DMVTLHRFLV MVQEDYHSQN PYHNAVHAAD
181 VTQAMHCYLK EPKLASFLTP LDIMLGLLAA AAHDVDHPGV NQPFLIKTNH HLANLYQNMS
241 VLENHHWRST IGMLRESRLL AHLPKEMTQD IEQQLGSLIL ATDINRQNEF LTRLKAHLHN
301 KDLRLEDAQD RHFMLQIALK CADICNPCRI WEMSKQWSER VCEEFYRQGE LEQKFELEIS
361 PLCNQQKDSI PSIQIGFMSY IVEPLFREWA HFTGNSTLSE NMLGHLAHNK AQWKSLLPRQ
421 HRSRGSSGSG PDHDHAGQGT ESEEQEGDSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE7B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 15 nTPM
- ovary: 11 nTPM
- seminal vesicle: 9.7 nTPM
- tongue: 8.3 nTPM
- endometrium: 7.3 nTPM
- smooth muscle: 7.1 nTPM
Single-cell type
- pituicytes/fscs: 2,708 nCPM
- podocytes: 907 nCPM
- renal collecting duct principal cells: 673 nCPM
- myosatellite cells: 631 nCPM
- medullary thymic epithelial cells: 547 nCPM
- astrocytes: 539 nCPM
Immune cell
- naive B-cell: 1.3 nTPM
- myeloid DC: 0.8 nTPM
- naive CD4 T-cell: 0.5 nTPM
- memory B-cell: 0.4 nTPM
- classical monocyte: 0.3 nTPM
- naive CD8 T-cell: 0.3 nTPM
Brain region
- basal ganglia: 55 nTPM
- hypothalamus: 43 nTPM
- midbrain: 34 nTPM
- thalamus: 30 nTPM
- amygdala: 23 nTPM
- medulla oblongata: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.55
- gnomAD missense Z
- 1.37
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cAMP catabolic process
- chemical synaptic transmission
- negative regulation of cAMP/PKA signal transduction
- signal transduction
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE7B as an antibody target. Whether an autoantibody or antibody against PDE7B could matter depends on whether native PDE7B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE7B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDE7B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...